Tumour mutations in long noncoding RNAs enhance cell fitness
Metadatos
Afficher la notice complèteEditorial
Springer Nature
Date
2023-06-08Referencia bibliográfica
Esposito, R., Lanzós, A., Uroda, T. et al. Tumour mutations in long noncoding RNAs enhance cell fitness. Nat Commun 14, 3342 (2023). [https://doi.org/10.1038/s41467-023-39160-7]
Patrocinador
Swiss National Science Foundation through the National Centre of Competence in Research (NCCR) "RNA amp; Disease" 51NF40-182880; The elements of long noncoding RNA function 31003A_182337; Sinergia project "Regenerative strategies for heart disease via targeting the long noncoding transcriptome" 173738; Medical Faculty of the University and University Hospital of Bern; Helmut Horten Stiftung, Swiss Cancer Research Foundation 4534-08-2018; Science Foundation Ireland 18/FRL/6194 18/CRT/6214Résumé
Long noncoding RNAs (lncRNAs) are linked to cancer via pathogenic changes
in their expression levels. Yet, it remains unclear whether lncRNAs can also
impact tumour cell fitness via function-altering somatic “driver” mutations. To
search for such driver-lncRNAs, we here perform a genome-wide analysis of
fitness-altering single nucleotide variants (SNVs) across a cohort of 2583 primary
and 3527 metastatic tumours. The resulting 54 mutated and positivelyselected
lncRNAs are significantly enriched for previously-reported cancer
genes and a range of clinical and genomic features. A number of these lncRNAs
promote tumour cell proliferation when overexpressed in in vitro models. Our
results also highlight a dense SNV hotspot in the widely-studied NEAT1 oncogene.
To directly evaluate the functional significance of NEAT1 SNVs, we use in
cellulo mutagenesis to introduce tumour-like mutations in the gene and
observe a significant and reproducible increase in cell fitness, both in vitro and
in a mouse model. Mechanistic studies reveal that SNVs remodel the NEAT1
ribonucleoprotein and boost subnuclear paraspeckles. In summary, this work
demonstrates the utility of driver analysis for mapping cancer-promoting
lncRNAs, and provides experimental evidence that somatic mutations can act
through lncRNAs to enhance pathological cancer cell fitness.